Vanda Pharmaceuticals Inc (VNDA) — Financial Flexibility Index
Vanda Pharmaceuticals Inc (VNDA) has a Financial Flexibility Index of -0.18x as of December 2025. Free cash flow of $-29.32 Million (operating CF $-29.42 Million minus capex $102.00K) represents 0% of total liabilities ($161.76 Million). Also explore Vanda Pharmaceuticals Inc (VNDA) equity growth momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Vanda Pharmaceuticals Inc Financial Flexibility Index (2004–2025)
Historical Financial Flexibility Index trend for Vanda Pharmaceuticals Inc across 22 annual periods. Check VNDA strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Vanda Pharmaceuticals Inc (2004–2025)
Year-by-year free cash flow to debt coverage for Vanda Pharmaceuticals Inc. For the full company profile including market capitalisation, see VNDA market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.67x | $-108.44 Million | $-109.44 Million | $161.76 Million | ▼ -416.7% |
| 2024 | -0.13x | $-15.27 Million | $-15.76 Million | $117.66 Million | ▼ -201.9% |
| 2023 | 0.13x | $13.18 Million | $12.80 Million | $103.53 Million | ▼ -58.3% |
| 2022 | 0.31x | $32.66 Million | $31.98 Million | $107.05 Million | ▼ -58.1% |
| 2021 | 0.73x | $64.77 Million | $64.21 Million | $88.86 Million | ▲ +9.1% |
| 2020 | 0.67x | $53.57 Million | $51.77 Million | $80.19 Million | ▲ +3.6% |
| 2019 | 0.65x | $46.97 Million | $45.95 Million | $72.80 Million | ▼ -33.9% |
| 2018 | 0.98x | $55.35 Million | $29.99 Million | $56.71 Million | ▲ +22755.2% |
| 2017 | 0.00x | $-319.00K | $-1.98 Million | $74.04 Million | ▲ +94.9% |
| 2016 | -0.08x | $-6.70 Million | $-8.10 Million | $79.04 Million | ▼ -145.3% |
| 2015 | 0.19x | $14.98 Million | $12.45 Million | $80.02 Million | ▲ +102.8% |
| 2014 | -6.69x | $-72.78 Million | $-81.55 Million | $10.89 Million | ▼ -1583.0% |
| 2013 | -0.40x | $-39.42 Million | $-39.59 Million | $99.22 Million | ▼ -16.2% |
| 2012 | -0.34x | $-42.90 Million | $-44.92 Million | $125.54 Million | ▼ -81.1% |
| 2011 | -0.19x | $-28.14 Million | $-28.41 Million | $149.14 Million | ▼ -203.6% |
| 2010 | -0.06x | $-10.90 Million | $-10.90 Million | $175.37 Million | ▼ -106.9% |
| 2009 | 0.89x | $181.34 Million | $169.34 Million | $202.68 Million | ▲ +107.8% |
| 2008 | -11.50x | $-45.01 Million | $-45.96 Million | $3.91 Million | ▼ -194.1% |
| 2007 | -3.91x | $-51.36 Million | $-51.64 Million | $13.13 Million | ▲ +26.1% |
| 2006 | -5.29x | $-50.27 Million | $-51.62 Million | $9.50 Million | ▼ -54.5% |
| 2005 | -3.42x | $-17.42 Million | $-17.71 Million | $5.09 Million | ▲ +24.5% |
| 2004 | -4.53x | $-8.20 Million | $-8.61 Million | $1.81 Million | — |